Signaling Pathways
- A3966 Doxorubicin3 CitationSummary: Topo II inhibitor,immunosuppresive antineoplastic antibiotic
- A4605 KU 559331 CitationSummary: ATM inhibitor,potent and selective
- A2402 FloxuridineTarget: Synthases/SynthetasesSummary: Antineoplastic antimetabolite
- A2171 CarboplatinSummary: Antitumor agent that forms platinum-DNA adducts.
- A1832 Doxorubicin (Adriamycin) HCl2 CitationTarget: TopoisomerasesSummary: Antitumour antibiotic,inhibits TOPO II.
- A2877 Camptothecin1 CitationTarget: TopoisomerasesSummary: Topoisomerase I inhibitor,prototypic
- A1402 Gemcitabine HClSummary: Inhibits DNA synthesis,deoxycytidine analog
- A1412 ClofarabineSummary: Antimetabolite,inhibit DNA polymerase and ribonucleotide reductase
- A1313 GatifloxacinSummary: Fluoroquinolone antibiotic,inhibits bacterial TOPO II
- A2852 LeflunomideSummary: AHR agonist,immunosuppressive agent